Cosmo Pharmaceuticals N.V. / Key word(s): Study resultsCosmo announces successful Phase III clinical trial of Lumeblue™ in China 14.12.2022 / 06:00 GMT/BST Dublin, Ireland – 14 December 2022: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) today announced the successful phase III clinical trial of Lumeb...
Related Keywords
China , Ireland , Dublin , Falk Gmbh , Hazel Winchester , Cosmo Pharmaceuticalsnv Key , Cosmo Pharmaceuticals , Medtronic , Red Hill Biopharma Ltd , Holdings Limited , China Medical System , Red Hill Biopharma ,
comparemela.com © 2020. All Rights Reserved.